Results 21 to 30 of about 250,188 (305)

ATOME-MORU/dexamethasone-: Dexamethasone cost effectiveness

, 2020
Code release accompanying the paper entitled: "The potential health and economic impact of dexamethasone treatment for patients with COVID-19" Authors: Ricardo Águas, Adam Mahdi, Rima Shretta, Peter Horby, Martin Landray, Lisa White, and the CoMo ...
ricardoaguas
core   +1 more source

Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90. [PDF]

PLoS ONE, 2012
Dexamethasone is widely used for pulmonary exacerbation in patients with cystic fibrosis, however, not much is known about the effects of glucocorticoids on the wild-type cystic fibrosis channel transmembrane regulator (CFTR).
Luiz Felipe M Prota, Liudmila Cebotaru, Jie Cheng, Jerry Wright, Neeraj Vij, Marcelo M Morales, William B Guggino   +6 more
doaj   +1 more source

Impact of Perioperative Dexamethasone on Hospital Length of Stay and Glycemic Control in Patients With Type 2 Diabetes Undergoing Total Hip Arthroplasty

Journal of Patient-Centered Research and Reviews, 2023
Purpose: This study aimed to evaluate effects of perioperative dexamethasone on hospital length of stay (LOS) and glycemic control for patients with type 2 diabetes mellitus undergoing total hip arthroplasty (THA).
Vanessa Williams, Mohammad J. Uddin Ansari, Amruta Jaju, Stacey Ward, Daniel O'Keefe, Jumana Abdelkarim, Nicole Montes, Ula Tarabichi, Albert Botchway, Michael G. Jakoby IV   +9 more
doaj   +1 more source

Dexamethasone bovine pharmacokinetics [PDF]

European Journal of Drug Metabolism and Pharmacokinetics, 1991
Dexamethasone phosphate (DXM-PHO) is an ester which is quickly hydrolysed by the bovine and the dexamethasone (DXM) plasma half-life was 5.16 h. It has been demonstrated that 54 h after DXM-PHO injection, DXM concentrations were lower than 0.1 mg/ml.
Gaignage, Ph, Lognay, Georges C., Bosson, Danièle, Vertongen, D., Dreze, Ph, Marlier, Michel, Severin, Michel   +6 more
openaire   +3 more sources

Treatment of oral chronic graft-versus-host disease: a retrospective cohort study

Einstein (São Paulo), 2021
Objective The aim of this study was to evaluate patients with complete response of oral chronic graft-versus-host disease to immunosuppressive treatment.
Gabriela de Assis Ramos, Taísa Domingues Boehmer Leite, Camila Brandão Lobo, Paulo Sérgio da Silva Santos, Maria Claudia Rodrigues Moreira, Héliton Spindola Antunes   +5 more
doaj   +2 more sources

Comparison of the efficacy of cardamom (Elettaria cardamomum) with pioglitazone on dexamethasone-induced hepatic steatosis, dyslipidemia, and hyperglycemia in albino rats

Journal of Advanced Pharmaceutical Technology & Research, 2015
To evaluate the efficacy of cardamom with pioglitazone on dexamethasone-induced hepatic steatosis, dyslipidemia, and hyperglycemia in albino rats. There were four groups of 6 rats each.
G M Nitasha Bhat, Nagendra Nayak, K Vinodraj, N Chandralekha, Paul Mathai, J Cherian   +5 more
doaj   +1 more source

Qualitative and Quantitative Analysis of Dexamethasone in Rheumatic Pain Herbal Medicine Using Thin-Layer Chromatography (TLC) – Densitometry

Journal of Fundamental and Applied Pharmaceutical Science, 2021
Chemical medicine is chemical substances that is used as the main ingredient of chemical drugs. This compound is usually added to herbal medicine preparation to strengthen the indication of the traditional medicine.Chemical medicine was prohibited from ...
Desy Ayu Irma Permatasari, Novita Kurniasri, Muladi Putra Mahardika   +2 more
doaj   +1 more source

Dexamethasone Effect on Sudden Hearing Loss is Validated in Stress-induced Animal Models: Hypothetical Study

, 2023
BACKGROUND: Stress could be a contributing cause of sudden hearing loss. This study intended to develop an animal model of stress-induced sudden hearing loss and to evaluate the effects of dexamethasone.
Kim, YJ, Yun-Hoon Choung1, Jang, JH, Yeong Cheol Kim, Oak-Sun Choo, Yun Yeong Lee, Choo, OS, Yun-Hoon Choung, Choung, YH, Jin-Sol Lee, Lee, YY, Yeon Ju Kim, Kim, YC, Oak-Sung Choo, Jeong Hun Jang, Lee, JS   +15 more
core   +1 more source

Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in a Predominantly African American Cohort

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2021
Objective: To explore the survival benefit of tofacitinib in addition to dexamethasone in hospitalized patients treated for coronavirus disease 2019 (COVID-19)–related pneumonia.
Maroun E. Hayek, MD, Michael Mansour, MD, Harrison Ndetan, MPH, MD, PhD, Quentin Burkes, PharmD, Robert Corkern, MD, Ammar Dulli, MD, Reya Hayek, BS, Karim Parvez, MD, Satwinder Singh, MD   +8 more
doaj   +1 more source

Nanoparticle-in-Hydrogel Delivery System for the Sequential Release of Two Drugs

Pharmaceutics
Background/Objectives: Glioblastoma is the most common and lethal primary brain tumor. Patients often suffer from tumor- and treatment induced vasogenic edema, with devastating neurological consequences.
Demian van Straten, Jaime Fernández Bimbo, Wim E. Hennink, Tina Vermonden, Raymond M. Schiffelers   +4 more
doaj   +1 more source